Table 4.
NC | MCI | AD | |||||
r | p | r | p | r | p | ||
AxD | frontal | 0.07 | 0.74 | .130 | 0.51 | –0.24 | 0.24 |
insula | 0.05 | 0.80 | –0.14 | 0.51 | –0.37 | 0.07 | |
limbic | –0.05 | 0.81 | –0.004 | 0.98 | –0.45 | 0.05 | |
occipital | 0.09 | 0.67 | –0.18 | 0.37 | –0.39 | 0.05 | |
parietal | 0.05 | 0.78 | 0.02 | 0.92 | –0.42 | 0.04 | |
temporal | –0.1 | 0.61 | 0.21 | 0.30 | –0.53 | 0.007 | |
MD | frontal | 0.12 | 0.55 | 0.19 | 0.36 | –0.29 | 0.16 |
insula | 0.02 | 0.90 | –0.25 | 0.23 | –0.14 | 0.50 | |
limbic | 0.12 | 0.56 | –0.03 | 0.86 | –0.39 | 0.05 | |
occipital | 0.04 | 0.83 | –0.12 | 0.54 | –0.40 | 0.05 | |
parietal | 0.11 | 0.59 | –0.02 | 0.91 | –0.49 | 0.01 | |
temporal | 0.01 | 0.96 | 0.17 | 0.41 | –0.49 | 0.01 | |
RD | frontal | 0.07 | 0.72 | 0.14 | 0.50 | –0.30 | 0.14 |
insula | –0.004 | 0.98 | –0.22 | 0.28 | –0.02 | 0.91 | |
limbic | 0.06 | 0.76 | –0.003 | 0.98 | –0.37 | 0.07 | |
occipital | 0.09 | 0.65 | –0.07 | 0.74 | –0.39 | 0.05 | |
parietal | 0.11 | 0.60 | –0.02 | 0.90 | –0.51 | 0.01 | |
temporal | –0.08 | 0.69 | 0.17 | 0.41 | –0.48 | 0.01 | |
FA | frontal | –0.07 | 0.72 | –0.28 | 0.17 | 0.12 | 0.57 |
insula | –0.08 | 0.69 | 0.21 | 0.31 | 0.46 | 0.06 | |
limbic | –0.1 | 0.57 | –0.1 | 0.63 | 0.19 | 0.35 | |
occipital | 0.08 | 0.68 | –0.11 | 0.58 | 0.29 | 0.16 | |
parietal | –0.2 | 0.32 | 0.002 | 0.99 | 0.37 | 0.07 | |
temporal | 0.006 | 0.97 | 0.1 | 0.62 | 0.17 | 0.41 |
MMSE, Mini-Mental State Examination; AxD, axial diffusion; MD, mean diffusion; RD, radial diffusion; FA, fractional anisotropy; NC, normal controls; MCI, mild cognitive impairment; AD, Alzheimer’s disease. p < 0.05 was considered statistically significant and bold font indicates statistical significance.